Gang Wang | Molecular Mechanisms Signaling | Best Researcher Award

Posted on by sciencefather

Prof. Gang Wang | Molecular Mechanisms Signaling | Best Researcher Award

Prof. Gang Wang , the First Affiliated Hospital of Harbin Medical University, China

Professor Wang Gang, MD, Ph.D., is a renowned general surgeon, postdoctoral researcher, and director of the Department of Oncology and Laparoscopy Surgery at The First Affiliated Hospital of Harbin Medical University, China. Specializing in pancreatic diseases, he is a prominent researcher and educator, with a focus on acute pancreatitis. He has contributed extensively to translational research, bridging molecular mechanisms to clinical innovations. As a high-level talent in Heilongjiang Province, he has published 166 works, including high-impact studies on ferroptosis and necroptosis in pancreatic diseases. With multiple editorial roles and leadership in various academic associations, Professor Wang continues to drive interdisciplinary advances in pancreatic disease management and surgery.

Publication Profile:

Google Scholar

Strengths for the Award:

Professor Wang Gang has demonstrated exceptional contributions to the field of pancreatic diseases, particularly in acute pancreatitis. His groundbreaking research on ferroptosis, necroptosis, and mitochondrial autophagy has resulted in a significant body of work with over 166 publications, many of which are high-impact studies. As a Principal Investigator, he has successfully led multiple National Natural Science Foundation projects, contributing innovative diagnostic and therapeutic strategies that have advanced the management of pancreatic diseases. His editorial roles in prominent journals and his collaborations with pharmaceutical companies reflect his recognition as a leader in the field. Moreover, his numerous provincial awards, including the Heilongjiang Science & Technology Progress First Prizes, further affirm his leadership and expertise.

Areas for Improvements:

While Professor Wang has achieved great success in pancreatic disease research, his work could benefit from expanding into interdisciplinary collaborations with other medical specialties to further enhance the clinical translation of his findings. Additionally, increasing the international visibility of his work through more international collaborations or partnerships could amplify its impact.

Education:

Professor Wang Gang holds both an MD and a Ph.D., specializing in general surgery. He completed his advanced postdoctoral training focusing on pancreatic diseases and advanced laparoscopic techniques. His rigorous academic journey has laid a strong foundation for his successful career in research, clinical practice, and teaching. Professor Wang’s educational experience reflects his deep commitment to advancing both his academic qualifications and medical expertise, leading to his leadership roles in multiple professional organizations and the development of several groundbreaking research projects in pancreatic health.

Experience:

Professor Wang has extensive clinical and research experience in pancreatic diseases. He serves as the Director of the Department of Oncology and Laparoscopy Surgery at The First Affiliated Hospital of Harbin Medical University. His research interests revolve around the pathogenesis and treatment of acute pancreatitis and other pancreatic disorders. In addition to his clinical role, he is a prolific academic leader, mentoring doctoral and postdoctoral researchers. With over 166 publications, he has led significant projects funded by the National Natural Science Foundation and has collaborated with top pharmaceutical companies. He has also served in prominent editorial and peer reviewer roles for many scientific journals, solidifying his influence in the research community.

Awards and Honors:

Professor Wang Gang has received numerous prestigious awards, including multiple Heilongjiang Science & Technology Progress First Prizes (2024, 2021). As a High-Level Talent of Heilongjiang Province and Outstanding Talent of Heilongjiang New Century, he is recognized for his outstanding contributions to medical research. His work has also earned him multiple accolades for his leadership and research excellence. As a principal investigator, he has received several National Natural Science Foundation grants, marking him as a leading figure in the field of pancreatic diseases. His success reflects his commitment to advancing medical science and improving patient outcomes, particularly in pancreatic diseases.

Research Focus:

Professor Wang’s research primarily focuses on the molecular mechanisms underlying pancreatic diseases, including acute pancreatitis and pancreatic cancer. His work has identified key molecular pathways, such as ferroptosis and necroptosis, in the progression of these diseases. His translational research connects basic science with clinical applications, optimizing surgical protocols and diagnostic tools. His studies on mitochondrial dysfunction, autophagy imbalance, and exosomal crosstalk provide novel insights into disease pathogenesis and potential therapeutic strategies. As a leading researcher, he has contributed significantly to the understanding of pancreatic diseases and continues to push boundaries in both basic and clinical research.

Publications Top Notes:

  • Ferroptosis: Past, Present, and Future 📚, Cell Death & Disease, 2020

  • Long Noncoding RNA MALAT1 Promotes Aggressive Pancreatic Cancer Proliferation and Metastasis via Autophagy 📚, Molecular Cancer Therapeutics, 2016

  • A New Algorithm of Blind Color Image Watermarking Based on LU Decomposition 📚, Multidimensional Systems and Signal Processing, 2018

  • Early Prediction of Infected Pancreatic Necrosis Secondary to Necrotizing Pancreatitis 📚, Medicine, 2017

  • A Three-Dimensional Failure Criterion for Hard Rocks Under True Triaxial Compression 📚, Rock Mechanics and Rock Engineering, 2020

  • Plasma and Tumor Levels of Linc-pint as Diagnostic and Prognostic Biomarkers for Pancreatic Cancer 📚, Oncotarget, 2016

  • The Effect of Emodin-Assisted Early Enteral Nutrition on Severe Acute Pancreatitis 📚, Mediators of Inflammation, 2007

  • Hydrogen Sulphide Exacerbates Acute Pancreatitis by Over-Activating Autophagy via AMPK/mTOR Pathway 📚, Journal of Cellular and Molecular Medicine, 2016

  • Necroptosis: A Potential, Promising Target in Acute Pancreatitis 📚, Apoptosis, 2016

  • Effects of Carbon Monoxide Releasing Molecule-Liberated CO on Severe Acute Pancreatitis in Rats 📚, Cytokine, 2010

  • A Novel Blind Color Image Watermarking Based on Contourlet Transform and Hessenberg Decomposition 📚, Multimedia Tools and Applications, 2018

Conclusion:

Professor Wang Gang is an exemplary candidate for the Best Researcher Award due to his impressive academic achievements, groundbreaking contributions to pancreatic disease research, and his ongoing efforts to bridge basic science and clinical practice. His work has not only advanced our understanding of acute pancreatitis but has also paved the way for potential therapeutic advancements. His leadership in research, publications, and collaboration highlights his remarkable contributions to the medical and scientific community.

Xueru Li | Molecular Mechanisms Signaling | Cell Microenvironment Award

Posted on by sciencefather

Ms. Xueru Li | Molecular Mechanisms Signaling | Cell Microenvironment Award

Ms. Xueru Li , Chongqing Medical University , China

Li Xueru is an accomplished researcher and scientist with expertise in clinical laboratory diagnostics. He obtained his Ph.D. in Clinical Laboratory Diagnostics from Chongqing Medical University. Xueru has contributed extensively to scientific research, particularly in the field of cell microenvironment, fibrosis, and oxidative stress. His research has involved collaborations with prestigious organizations, such as the Chongqing Education Commission and Chongqing Natural Science Foundation. Through his academic journey, he has demonstrated a strong commitment to advancing knowledge in biomedical sciences, particularly in the areas of lung fibrosis and cellular response to environmental stress. Li Xueru is an active participant in research projects and has co-authored several influential publications that have contributed to the advancement of molecular biology and clinical diagnostics.

Publication Profile:

Scopus

Strengths for the Award:

Li Xueru’s expertise in clinical laboratory diagnostics, combined with his research in the field of cell microenvironment and fibrosis, positions him as a strong candidate for the Research for Cell Microenvironment Award. His work, especially the study on “Pharmaceutical targeting of succinate dehydrogenase in fibroblasts to control bleomycin-induced lung fibrosis,” highlights his contributions to understanding cellular mechanisms in fibrosis and oxidative stress. His involvement in high-impact research funded by organizations like the Chongqing Education Commission and the Chongqing Natural Science Foundation shows a commitment to advancing scientific knowledge and contributing to both academic and practical advancements in biomedical sciences. Moreover, his ability to bridge fundamental research with clinical applications demonstrates a strength that aligns with the goals of the Research for Cell Microenvironment Award.

Areas for Improvements:

While Li Xueru’s research focus is promising, there is potential to expand his exploration of cellular microenvironment to include other disease models and extend beyond lung fibrosis. Diversifying his research topics could provide a broader understanding of cellular behavior across different tissues and disease states. Additionally, there could be more emphasis on the development of therapeutic interventions, potentially accelerating the translation of his discoveries into clinical practices. Increasing collaboration with international research teams may also offer new perspectives and further enhance the impact of his work.

Education:

Li Xueru earned his Ph.D. degree in Clinical Laboratory Diagnostics from Chongqing Medical University, one of China’s leading medical institutions. His academic background has provided him with in-depth knowledge of diagnostic technologies, clinical pathology, and molecular biology. During his doctoral studies, he developed expertise in understanding cellular behavior and disease mechanisms at the molecular level, with a particular focus on how environmental stress impacts cellular functions. This education laid the foundation for his career in the biomedical field. He has further strengthened his research skills by participating in various projects funded by the Chongqing Education Commission and the Chongqing Natural Science Foundation. His education has been instrumental in shaping his approach to scientific inquiry, fostering a comprehensive understanding of clinical diagnostics, and equipping him to lead innovative research in the cellular microenvironment and disease mechanisms.

Experience:

Li Xueru’s experience spans a wide range of research activities focused on clinical laboratory diagnostics and cell microenvironment. His involvement in multiple high-impact research projects, supported by institutions like the Chongqing Education Commission and the Chongqing Natural Science Foundation, showcases his leadership in advancing scientific knowledge. Xueru has worked closely with interdisciplinary teams to address complex problems in the biomedical field, particularly lung fibrosis and oxidative stress. His research contributions include identifying novel cellular mechanisms involved in disease pathogenesis, improving diagnostic methodologies, and exploring therapeutic strategies for disease management. He has demonstrated a remarkable ability to apply scientific research in real-world contexts, ensuring that his findings have practical applications in medical diagnostics and treatment. His collaborative approach and innovative thinking have positioned him as a key figure in his field, contributing significantly to both academic literature and clinical advancements.

Research Focus:

Li Xueru’s primary research focus revolves around the molecular mechanisms of diseases, particularly lung fibrosis and cellular responses to environmental stressors. He is dedicated to understanding the impact of oxidative stress on cellular functions and its role in disease progression. His research explores the microenvironment of cells in response to various stimuli, including chemical agents like bleomycin. A significant area of his research is the role of succinate dehydrogenase in fibroblasts and its potential as a pharmaceutical target to control lung fibrosis. Through his work, Xueru has contributed to a better understanding of how cells interact with their microenvironment, which is crucial for developing new diagnostic and therapeutic approaches. His innovative studies on cell signaling pathways, fibrosis, and oxidative stress have the potential to transform treatment strategies for diseases related to chronic inflammation and tissue fibrosis.

Publications Top Notes:

  • Pharmaceutical targeting of succinate dehydrogenase in fibroblasts controls bleomycin-induced lung fibrosis 🧬

  • Corrigendum to “Pharmaceutical targeting of succinate dehydrogenase in fibroblasts controls bleomycin-induced lung fibrosis” 🔬

Conclusion:

Li Xueru is a promising candidate for the Research for Cell Microenvironment Award. His significant contributions to the understanding of cellular mechanisms in fibrosis and oxidative stress have led to valuable insights into the pathophysiology of diseases. By focusing on the cell microenvironment and its role in disease progression, his work is advancing scientific knowledge with important implications for diagnostics and therapy. With further diversification of his research and expanded collaborations, Li Xueru has the potential to make even greater strides in the field, ultimately improving patient outcomes and advancing the application of his findings in clinical settings.

Sheng-Chi Hsu | molecular diagnosis | Best Researcher Award

Posted on by sciencefather

Mrs. Sheng-Chi Hsu | molecular diagnosis | Best Researcher Award

Mrs. Sheng-Chi Hsu , Department of Laboratory Medicaine, Chang Gung Memorial Hospital at LinKou , Taiwan

Sheng-Chi Hsu, M.S., is a leading expert in tumor biology, molecular pathology, and personalized medicine. Currently serving as the Deputy Director of the Department of Laboratory Medicine at Chang Gung Memorial Hospital, Linkou Branch, he has extensive experience in cancer diagnostics, molecular pathology, and clinical research. With a strong academic background and a commitment to advancing medical science, Hsu has contributed significantly to the field of oncology, focusing on novel diagnostic approaches and precision medicine strategies. His research has resulted in several impactful publications, enhancing diagnostic accuracy and the development of targeted therapies for various cancers. Hsu’s work has played a pivotal role in improving patient outcomes and shaping the future of cancer treatment in Taiwan.

Publication Profile: 

Scopus

Strengths for the Award:

Sheng-Chi Hsu has demonstrated exceptional expertise in tumor biology, molecular pathology, and personalized medicine, contributing to groundbreaking advancements in cancer diagnostics and precision medicine. His leadership roles at Chang Gung Memorial Hospital, particularly in the Department of Laboratory Medicine and Pathology, showcase his ability to manage large teams and oversee complex laboratory operations while pushing the boundaries of research. His publications in prestigious journals highlight significant research achievements, including the identification of key biomarkers for cancer therapies and advancing molecular diagnostic techniques. Hsu’s research on cancer biomarkers, including ALK translocation and ROS1 translocation in non-small cell lung cancer (NSCLC), has provided valuable insights into targeted therapies, which are directly influencing patient care and therapeutic approaches. His work on multidrug resistance also opens new therapeutic avenues to overcome chemotherapy resistance, making his contributions pivotal to modern cancer treatment strategies.

Areas for Improvements:

While Hsu’s research accomplishments are impressive, expanding his involvement in large-scale, multi-center clinical trials could further enhance the real-world application and validation of his research findings. Collaborating with international institutions or expanding his research scope to include more diverse populations may also increase the generalizability and impact of his findings. Additionally, although Hsu has an extensive background in molecular diagnostics, there may be room to explore emerging technologies, such as artificial intelligence in pathology, to further optimize diagnostic procedures and improve precision medicine outcomes.

Experience:

Sheng-Chi Hsu has over 15 years of experience in laboratory medicine and pathology, with expertise in tumor pathology and molecular diagnostics. He is currently the Deputy Director of the Department of Laboratory Medicine at Chang Gung Memorial Hospital, where he leads research and development in laboratory diagnostics. Previously, he served as the Deputy Director of the Department of Pathology, overseeing innovations in histopathological diagnostics. Hsu’s leadership has been instrumental in advancing cancer diagnostics, optimizing molecular diagnostic techniques, and improving laboratory workflows. His career also includes roles as a Chief and Senior Medical Technologist, where he pioneered research in tumor pathology, focusing on biomarker identification and the development of diagnostic assays.

Research Focus:

Sheng-Chi Hsu’s research focuses on advancing molecular diagnostics, particularly in oncology. His work aims to enhance diagnostic precision for various cancers, with a strong emphasis on personalized medicine. Hsu has made significant contributions to the genetic characterization of tumors, identifying key biomarkers for targeted therapies in non-small cell lung cancer (NSCLC), synovial sarcoma, and gestational trophoblastic disease. His research in multidrug resistance mechanisms and the role of Wnt5A in cancer therapy has opened new avenues for overcoming chemoresistance. Hsu’s pioneering studies in molecular pathology have significantly impacted clinical practices, helping improve treatment strategies and patient outcomes through advanced diagnostics.

Publications Top Notes:

  1. Wang HS, Liu CY, Hsu SC, Huang SC, Hung TH, Ng KF, Chen TC. A Single-Institute Experience with C-ros Oncogene 1 Translocation in Non-Small Cell Lung Cancers in Taiwan. Int J Mol Sci. 2022 May 21;23(10):5789. 📄
  2. Hsu SC, Hung TH, Wang CW, Ng KF, Chen TC. Anaplastic lymphoma kinase translocation is correlated with anaplastic lymphoma kinase expression and mutually exclusive with epidermal growth factor receptor mutation in Taiwanese non-small cell lung cancer. Pathol Int. 2015 May;65(5):231-9. 📄
  3. Hung TH, Hsu SC, Cheng CY, Choo KB, Tseng CP, Chen TC, Lan YW, Huang TT, Lai HC, Chen CM, Chong KY. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway. Oncotarget. 2014 Dec 15;5(23):12273-90. 📄
  4. Chen KH, Hsu SC, Chen HY, Ng KF, Chen TC. Utility of fluorescence in situ hybridization for ploidy and p57 immunostaining in discriminating hydatidiform moles. Biochem Biophys Res Commun. 2014 Apr 4;446(2):555-60. 📄
  5. Chuang HC, Hsu SC, Huang CG, Hsueh S, Ng KF, Chen TC. Reappraisal of TLE-1 immunohistochemical staining and molecular detection of SS18-SSX fusion transcripts for synovial sarcoma. Pathol Int. 2013 Dec;63(12):573-80. 📄

Conclusion:

Sheng-Chi Hsu is highly deserving of the “Best Researcher Award” due to his outstanding contributions to cancer research and diagnostic advancements. His innovative approach to tumor pathology and molecular diagnostics, along with his leadership in clinical and research operations, makes him a transformative figure in the field. With a continued focus on expanding his research scope and incorporating emerging technologies, Hsu’s impact on personalized cancer treatments is poised to grow even further.

Felicia ANTOHE | Molecular Mechanisms Signaling | Molecular Cell Biology Award

Posted on by sciencefather

Dr. Felicia ANTOHE | Molecular Mechanisms Signaling | Molecular Cell Biology Award

Dr. Felicia ANTOHE , Inst. Cellular Biology and Pathology NS , Romania

Dr. Felicia Antohe is the Head of the Proteomics Department at the Institute of Cellular Biology and Pathology, Romanian Academy. With a background in cellular biology and biophysics, she has contributed significantly to biomedical research, particularly in vascular endothelium, atherosclerosis, diabetes, and immune disorders. She has received multiple prestigious awards and conducted pioneering research, especially on the transcytosis of macromolecules in endothelial cells. As a PhD advisor, she mentors young researchers, having guided 12 PhD students to date. Dr. Antohe is an internationally recognized expert with extensive experience in immunology, cell biology, and proteomics.

Publication Profile:

Google Scholar

Strengths for the Award:

Dr. Felicia Antohe stands out as an exceptional candidate for the Research for Molecular Cell Biology Award due to her extensive academic and research achievements. As Head of the Proteomics Department at the Institute of Cellular Biology and Pathology, Romanian Academy, her leadership in pioneering research in endothelial cell biology and vascular pathologies has been transformative. Dr. Antohe’s strong academic background, with a Master’s in Biophysics and a PhD in Cellular Biology, complements her robust research portfolio. With over 170 scientific papers, 90 of which are indexed in Web of Science, she is recognized for her contributions to molecular mechanisms in diseases such as atherosclerosis, diabetes, and immune disorders. Furthermore, her work on monoclonal antibodies and proteomics has had a significant impact on both scientific and clinical advancements.

Areas for Improvement:

While Dr. Antohe’s research is highly regarded, there is potential for greater integration of her research with cutting-edge technologies in bioinformatics and computational biology. This could further expand her work on proteomics and molecular mechanisms. Additionally, there is an opportunity for broader outreach to apply her findings in practical therapeutic contexts through collaborations with pharmaceutical companies or clinical trials. Expanding her influence in translational research could have a larger impact on public health, especially in diseases such as diabetes and cardiovascular disorders.

Education:

Dr. Felicia Antohe holds a Master’s degree in Biophysics from the University of Bucharest (1977). She completed her PhD in Cellular Biology at the Romanian Academy’s Institute of Cellular Biology and Pathology (1994). In addition to her formal education, she has been a PhD coordinator since 2000 and has contributed significantly to research training at national and international levels. Her work blends theoretical knowledge with cutting-edge lab techniques in molecular biology, proteomics, and immunology.

Experience:

Dr. Antohe’s research experience spans numerous roles. She is currently the Principal Investigator and Member of the Scientific Council at the Romanian Academy’s Institute of Cellular Biology and Pathology. She has also worked as a visiting scientist at prestigious institutions like McGill University, University of Alberta, and Max Planck Institute. She has coordinated over 44 research projects, including national and international grants, and is actively involved in multiple collaborative research efforts across Europe and beyond. Her leadership in cell biology and proteomics is widely recognized.

Awards and Honors:

Dr. Antohe has received numerous awards, including the EURESCO Prize (2001), the BIO-RAD Laboratories Prize for valuable research (2002), and the Romanian Academy Emil Racovita Prize (1991). She has also won multiple international recognitions for her scientific contributions, such as the Best Poster award at the “8th International Conference on Vascular Endothelium” (2005), and various fellowships and grants from organizations like COST and the European Science Foundation.

Research Focus:

Dr. Antohe’s research focuses on endothelial cell biology, particularly transcytosis, endocytosis, and cell receptor mechanisms in both health and disease. She investigates the bio-pathology of atherosclerosis, diabetes, and immune disorders, with particular attention to the transport of macromolecules across vascular cells. Her work also explores the role of monoclonal antibodies as diagnostic and therapeutic tools. She applies proteomic techniques to study endothelial cell function, aiming to understand vascular biology at molecular and cellular levels.

Publications Top Notes:

  • The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans 📄
  • Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice 📄
  • Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey 📄
  • Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells 📄
  • Analytical techniques for multiplex analysis of protein biomarkers 📄
  • Functional ultrastructure of the vascular endothelium: changes in various pathologies 📄
  • Effect of enoxaparin on high glucose-induced activation of endothelial cells 📄
  • Albumin-binding proteins function in the receptor-mediated binding and transcytosis of albumin across cultured endothelial cells 📄
  • Carbapenemase-Producing Klebsiella pneumoniae in Romania: A Six-Month Survey 📄
  • Establishment of a pure vascular endothelial cell line from human placenta 📄

Conclusion:

Dr. Felicia Antohe is an outstanding researcher whose work has greatly advanced our understanding of endothelial cell biology, molecular transport, and disease mechanisms. Her combination of technical expertise, leadership in multiple high-impact research projects, and numerous prestigious awards positions her as an ideal candidate for the Research for Molecular Cell Biology Award. While there is always room to expand her research applications, her contributions to science are already substantial and impactful.

 

 

 

Sunita Pokhrel Bhattarai | Signal Transduction Mechanisms | Women Researcher Award

Posted on by sciencefather

MS. Sunita Pokhrel Bhattarai | Signal Transduction Mechanisms | Women Researcher Award

Ms. Sunita Pokhrel Bhattarai  , Ohio State University , United States

Sunita Pokhrel Bhattarai, PhD, RN, is an accomplished cardiovascular nurse researcher currently pursuing a doctorate at the University of Rochester, New York. Her research focuses on improving the estimation of Left Ventricular Ejection Fraction using ECGs in acute heart failure patients. With a background in emergency and critical care nursing from multiple international institutions, she is committed to advancing healthcare quality, particularly in heart failure care. Dr. Pokhrel Bhattarai’s work is widely published, showcasing expertise in clinical trials, big data analysis, and electrocardiographic assessments in heart failure. She has also contributed significantly to nursing education as a lecturer at Purbanchal University, Nepal. Passionate about reducing healthcare discrepancies, she actively participates in academic and clinical research collaborations, making significant strides in her field.

Publication Profile:

Google Scholar

Strengths for the Award:

Dr. Sunita Pokhrel Bhattarai is an exceptional researcher with a clear commitment to advancing cardiovascular nursing and improving healthcare outcomes for acute heart failure patients. Her research on estimating Left Ventricular Ejection Fraction using ECGs demonstrates innovation and clinical relevance. Her ability to bridge clinical practice with advanced research methodologies, including big data analysis and electrocardiographic assessment, sets her apart. Moreover, her international academic background and diverse professional experience in countries like Nepal, Spain, and the United States highlight her versatility and ability to contribute globally to healthcare solutions. Dr. Pokhrel Bhattarai’s consistent publication record in top-tier journals and her involvement in prestigious research projects further underscores her dedication to advancing nursing knowledge.

Areas for Improvement:

While Dr. Pokhrel Bhattarai has an outstanding academic and research profile, expanding her research to explore broader healthcare disparities, particularly in rural or underserved populations, could enhance the impact of her work. Additionally, pursuing interdisciplinary collaborations with engineers, statisticians, and other healthcare professionals could provide opportunities for more cutting-edge innovations, particularly in ECG-based diagnostic technology and AI integration.

Education:

Dr. Sunita Pokhrel Bhattarai has an extensive academic background. She is currently pursuing a PhD in Health Science and Nursing at the University of Rochester (2020-2024), under the mentorship of Dr. Mary G Carey. Her research explores estimating Left Ventricular Ejection Fraction using ECGs for acute heart failure patients. Dr. Pokhrel Bhattarai earned her MS in Nursing (2015-2017), specializing in Emergency and Critical Care Nursing, from institutions across Spain, Portugal, and Finland. Her research during this time focused on Advanced Cardiac Life Support knowledge among critical care nurses. She completed her BS in Nursing in 2012 from Maharajgunj Nursing Campus, Nepal, with a focus on Community Health Nursing. Throughout her academic career, she has demonstrated a commitment to advancing nursing knowledge and improving healthcare outcomes in cardiovascular care.

Experience:

Dr. Sunita Pokhrel Bhattarai has diverse professional experience across multiple countries. She has worked as a Nursing Lecturer at Purbanchal University in Kathmandu, Nepal (2017-2020), where she educated future nurses in critical care and advanced cardiovascular practices. As a registered nurse at Shahid Gangalal National Heart Centre, Kathmandu, Nepal (2009-2015), she gained hands-on experience in cardiovascular care, particularly in heart failure management. Additionally, she has been involved in research coordination and manuscript review, demonstrating expertise in big data analysis and clinical trials. Dr. Pokhrel Bhattarai has also held positions as a Research Lead Coordinator and Associate, collaborating with international researchers and contributing to advancing healthcare outcomes, particularly in cardiovascular nursing.

Awards and Honors:

Dr. Sunita Pokhrel Bhattarai has received numerous prestigious awards, highlighting her excellence in research and commitment to healthcare. In 2023, she was awarded the Travel Grant by the Council on Cardiovascular and Stroke Nursing Early Career, American Heart Association, and received the Presidential Stronger as One Diversity Award from the University of Rochester. She also secured a research grant from the International Society for Computerized Electrocardiology Conference. Dr. Pokhrel Bhattarai’s accomplishments include the Ireta Neumann Scholarship for International Nurses, providing $5,000 to support her research endeavors. These awards emphasize her leadership and contributions to cardiovascular nursing, both academically and clinically.

Research Focus:

Dr. Sunita Pokhrel Bhattarai’s research focus lies in the intersection of acute heart failure, ECG technology, and cardiovascular nursing. Her PhD dissertation explores estimating Left Ventricular Ejection Fraction using ECGs, aiming to provide accurate, non-invasive diagnostic tools for acute heart failure. She is passionate about identifying self-care strategies for heart failure patients and improving healthcare implementation strategies. Additionally, her work involves big data analysis, electrocardiographic assessment, and clinical trials to better understand heart failure progression and outcomes. Dr. Pokhrel Bhattarai is dedicated to addressing healthcare discrepancies, particularly in global cardiovascular health, and advancing evidence-based nursing practices through innovative research.

Publications Top Notes:

  1. Association Between Increased Serum Albumin and the Length of Hospital Stay among Acute Heart Failure 🏥
  2. Delays in Door-to-Diuretic Time and 1-Year Mortality among Patients with Heart Failure ⏳❤️
  3. Signs and Symptoms Clusters Among Patients With Acute Heart Failure 🔍💓
  4. Integrative Review of Electrocardiographic Characteristics in Patients with Reduced, Mildly Reduced, and Preserved Heart Failure 📊📈
  5. Knowledge and Practices on Prevention of Coronary Artery Diseases in Nepalese Community 🇳🇵💓
  6. Estimating Ejection Fraction from the 12 Lead ECG among Patients with Acute Heart Failure 💖📉
  7. Door-to-Diuretic Time is Related to Length of Hospital Stay Independent of Diuretic Dose ⏰💊
  8. Estimating Very Low Ejection Fraction from the 12 Lead ECG among Patients with Acute Heart Failure ❤️📉
  9. Association Between Serum Albumin and the Length of Hospital Stay Among Patients With Acute Heart Failure 🧑‍⚕️⏱
  10. Estimating Ejection Fraction from the 12 Lead ECG in Acute Heart Failure 💓📝

Conclusion:

Dr. Sunita Pokhrel Bhattarai’s combination of innovative cardiovascular research, global nursing expertise, and dedication to improving patient outcomes makes her an excellent candidate for the Research for Best Researcher Award. Her strong track record in research, awards, and contributions to cardiovascular nursing makes her deserving of this recognition, and her future endeavors hold great potential to further elevate the field of health science and nursing.

 

 

 

Bárbara Verçosa | Host-Pathogen Interactions | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Bárbara Verçosa | Host-Pathogen Interactions | Best Researcher Award

Prof. Dr. Bárbara Verçosa , Faculdade de Saude Pitágoras Codó , Brazil

Bárbara Laurice Araújo Verçosa, a Brazilian researcher and veterinarian, specializes in veterinary pathology and the study of leishmaniasis. She holds a Doctorate in Biology (2015) from Universidade Federal de Minas Gerais, with a focus on renal response in canine visceral leishmaniasis. She is a committed educator and scientific researcher, contributing extensively to the fields of veterinary medicine and animal pathology. She has published numerous papers in international journals, participated in various academic and professional events, and is an active member of editorial boards. Her contributions to veterinary science, especially in the study of inflammatory responses and apoptosis in leishmaniasis, have earned her recognition both nationally and internationally.

Publication Profile:

Scopus

Strengths for the Award:

  1. Academic Qualifications and Research Focus:
    Dr. Verçosa has a strong academic background, with a Doctorate in Biology from the Universidade Federal de Minas Gerais (UFMG) and a Master’s degree in Pathological Anatomy and Clinical Pathology from the same institution. Her research focuses on canine visceral leishmaniasis, which is highly relevant and impactful in veterinary medicine. Her expertise in apoptosis, inflammation, fibrosis, and renal pathology related to infectious diseases shows a high level of specialization and contribution to the field.
  2. Research Publications:
    Dr. Verçosa has an impressive publication record with 23 articles in reputable scientific journals, including high-impact journals such as Microbial Pathogenesis, Molecular Immunology, and Veterinary Parasitology. Additionally, she has authored books and chapters and has presented her research at numerous conferences. The breadth and depth of her publications demonstrate her active contribution to advancing knowledge in veterinary medicine, particularly in parasitic diseases.
  3. Experience and Knowledge:
    With significant experience in pathology, veterinary medicine, and molecular diagnostics, she brings a holistic understanding of both the basic and applied aspects of her field. Her experience in teaching, mentoring graduate students, and serving as a scientific journal referee further exemplifies her leadership in the academic and research community.
  4. Awards and Recognition:
    Dr. Verçosa’s work has been recognized with multiple awards such as the Menção Honrosa at the Seminário de Iniciação Científica and the 1st Prize in Scientific Initiation from Fapepi. These awards highlight her early career achievements and ongoing recognition in her research contributions.
  5. International Recognition and Collaborations:
    Dr. Verçosa is an active contributor to international research, with collaborations and refereeing roles in journals such as the Journal of Pharmaceutical Research International and the Asian Journal of Advances in Research, which reflects her international recognition and commitment to global scientific dialogue.

Areas for Improvement:

  1. Increase Interdisciplinary Collaborations:
    While Dr. Verçosa’s expertise is mainly within the veterinary and biological sciences domain, exploring interdisciplinary research with fields like public health, epidemiology, and clinical veterinary practices could further broaden the impact of her work, especially considering the public health implications of diseases like Leishmaniasis.
  2. Expanding Research into Novel Treatment Approaches:
    Given the ongoing challenges in treating Leishmaniasis in animals, expanding her research to explore new treatment protocols or innovative therapies in collaboration with clinicians could be a valuable area of growth. Exploring how her findings in inflammatory response and fibrosis can lead to better therapeutic options could strengthen the clinical relevance of her work.
  3. Increased Public Engagement:
    While her publications are substantial in academic circles, increasing public engagement through outreach programs or community awareness initiatives about canine Leishmaniasis and other diseases she studies could enhance her contribution to society. This could help bridge the gap between research and practical applications for the broader population.

Education:

Bárbara Verçosa holds a Doctorate (2015) in Biology from Universidade Federal de Minas Gerais (UFMG), Brazil, where she focused on inflammatory responses and apoptosis in dogs infected with Leishmania. She completed her Master’s in Pathological Anatomy and Clinical Pathology at UFMG in 2010, investigating apoptosis in naturally infected dogs. She earned her Veterinary Medicine degree from Universidade Federal do Piauí (UFPI) in 2007, specializing in the inflammatory responses in canine leishmaniasis. Additionally, Verçosa has participated in postdoctoral research at Universidade de Brasília (UnB), focusing on health sciences, and has completed several continuing education courses in diagnostic imaging, molecular diagnostics, and animal pathology.

Experience:

Verçosa has extensive academic and professional experience in veterinary medicine and pathology. She served as a faculty member at Universidade Regional do Cariri (URCA) and currently teaches at Faculdade de Ciências da Saúde Pitágoras Codó. She has been involved in research, graduate supervision, and clinical training in veterinary anatomy and pathology. Her research focus includes canine leishmaniasis, inflammatory responses, and apoptotic processes in infected tissues. Her career also includes several trainee and research positions, particularly in animal pathology at UFPI, and clinical practice in large animal surgery. Verçosa’s international exposure includes teaching and research roles at UFMG, where she taught pathology to veterinary students. Her involvement in research and scientific publication spans many years, with a focus on advancing the understanding of animal diseases through detailed anatomical and molecular studies.

Awards and Honors:

Bárbara Verçosa has received multiple awards for her research and academic contributions. Notably, she received two Honorable Mentions in 2006 for her presentations at the XIV Seminário de Iniciação Científica at UFPI. She was also awarded the 1st Prize for Scientific Initiation by Fapepi, the Foundation for Research Support of the State of Piauí, in 2005. These recognitions highlight her early dedication to scientific research. Verçosa’s career has also been distinguished by her scholarships from CAPES and CNPq, which supported her doctoral and master’s research. Her research excellence has been further validated by her ongoing involvement in prestigious journals as a reviewer, alongside her role in various editorial boards. Her academic achievements reflect her significant contributions to the fields of veterinary science and animal pathology.

Research Focus:

Bárbara Verçosa’s research primarily focuses on veterinary pathology, particularly in the context of visceral leishmaniasis in dogs. Her studies explore the inflammatory response, apoptosis, and fibrosis in organs affected by this parasitic disease. She investigates the molecular and histomorphometric changes in canine renal tissues, with an emphasis on the interactions between immune responses and tissue damage. Verçosa’s work also covers the role of chemokines, cytokines, and apoptosis markers in understanding the disease’s pathogenesis. Her research extends into other areas of veterinary pathology, including the study of animal inflammatory diseases and zoonotic diseases. Through her studies, she aims to contribute to improving diagnostic, therapeutic, and preventive measures for animal health. Verçosa’s interdisciplinary approach combines molecular biology, histopathology, and clinical studies, positioning her as a leading expert in veterinary parasitology.

Publications Top Notes:

  1. Enhanced apoptotic index in hepatocytes, Kupffer cells, and inflammatory infiltrate showed positive correlation with hepatic lesion intensity, parasite load, and clinical status in naturally Leishmania-infected dogs. (MICROBIAL PATHOGENESIS) 📚🦠
  2. MCP-1/IL-12 ratio expressions correlated with adventitial collagen depositions in renal vessels and IL4/IFN-γ expression correlated with interstitial collagen depositions in the kidneys of dogs with canine leishmaniasis. (MOLECULAR IMMUNOLOGY) 🧬🦠
  3. Nucleolar organizer region proteins enhancement in nucleoplasm’s of renal tubular cells is an indication of kidney impairment in Leishmania-infected dogs. (VETERINARY PARASITOLOGY) 🦠🧪
  4. Enhanced apoptotic index, chemokines and inflammatory recruitment in renal tissues shows relationship with the clinical signs in Leishmania-infected dogs. (VETERINARY PARASITOLOGY) 🔬🐶
  5. The balance between IL-12/IL4 in renal tissue switches the inflammatory response arm and shows relationship with the clinical signs in Leishmania-infected dogs (Veterinary Immunology and Immunopathology, 2021).

Conclusion:

Dr. Bárbara Laurice Araújo Verçosa is a highly accomplished and well-regarded researcher in the field of veterinary medicine, particularly in pathology and infectious diseases. Her extensive research publications, awards, and international collaborations are a testament to her expertise and impact in the field. The areas identified for improvement are relatively minor and pertain to enhancing the breadth and public visibility of her work. Overall, her scientific contributions make her an excellent candidate for the Best Researcher Award.